Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Pharmaceutical company Novo Nordisk has launched its mega-popular weight-loss drug Wegovy in China — but for a tiny fraction ...

Obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust results with the new medications.

Weight loss drugs like Ozempic and Wegovy have gained popularity for their ability to help users shed pounds, but medical ...

We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

One the bigger drivers of Medicaid’s rising costs is the ballooning expense of covering weight loss drugs, a state Senate ...

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...

More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.

Weight-loss drug makers are directly targeting employers in a campaign to expand health insurance coverage of their popular, ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

Slickly designed websites. Unbelievable markdowns. A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable ...

The U.S. Food and Drug Administration has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a higher risk of inhaling gastric contents ...